August 2018 Focus: Pharma Innovators, Top 200 Medicines, First Year After Launch, AR/VR and more!

Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.

This is a case study by TechEmergence, an artificial intelligence market research and media platform.

The CME provider Rockpointe launched the first CME-certified course ever offered on Amazon Echo through the AudioEducate platform with joint providers Potomac Center for Medical Education (PCME) and the Academy of Physicians in Clinical Research (APCR).

Continuing its efforts to address high prescription drug costs, insurer Highmark entered into a new outcomes-based contract with Boehringer Ingelheim for Jardiance (empagliflozin), an oral medicine indicated to lower blood sugar in adults with type 2 diabetes, and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease.

AstraZeneca and the health services organization Geisinger have partnered to improve asthma care by creating a suite of products that integrate into the electronic health record.

Quest Diagnostics

Physicians and health plan executives agree that healthcare has made little progress toward value-based care since last year, according to a survey by Quest Diagnostics.